OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How cancer hijacks the body’s homeostasis through the neuroendocrine system
Radomir M. Slominski, Chander Raman, Jake Y. Chen, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 4, pp. 263-275
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Photo-neuro-immuno-endocrinology: How the ultraviolet radiation regulates the body, brain, and immune system
Radomir M. Slominski, Jake Y. Chen, Chander Raman, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 14
Open Access | Times Cited: 54

Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances
Hyun Jee Kim, Yeong Ho Kim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2984-2984
Open Access | Times Cited: 19

VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives
Mohammad Malekan, Nikolas K. Haass, Ghasem Rahmatpour Rokni, et al.
Life Sciences (2024) Vol. 345, pp. 122563-122563
Closed Access | Times Cited: 16

Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Radomir M. Slominski, Tae‐Kang Kim, Zorica Janjetović, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2262-2262
Open Access | Times Cited: 15

Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities
Rajan Logesh, Sagar Rajendra Prasad, Sandhya Chipurupalli, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188968-188968
Closed Access | Times Cited: 30

Role of stress in the pathogenesis of cancer (Review)
Ioannis G. Lempesis, Vasiliki Georgakopoulou, Petros Papalexis, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 5
Open Access | Times Cited: 25

From pain to tumor immunity: influence of peripheral sensory neurons in cancer
Ugo Mardelle, Ninon Bretaud, Clara Daher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12

Melatonin and the Skin: Current Progress and Perspectives for Human Health
Andrzej Słomiński, Tae Kim, Zorica Janjetović, et al.
Journal of Investigative Dermatology (2025)
Closed Access

SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types
E. Verdier, Nathalie Gaspar, Maria Eugénia Marques Da Costa, et al.
Oncotarget (2025) Vol. 16, Iss. 1, pp. 51-62
Open Access

Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)
Dimitrios Andreikos, Demetrios�� Spandidos, Vasiliki Georgakopoulou
International Journal of Oncology (2025) Vol. 66, Iss. 3
Closed Access

Advances in targeted therapy and immunotherapy for melanoma (Review)
Ziyao Qin, Mei Zheng
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 14

Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis
Jonathan N. Priantti, Maysa Vilbert, Thiago Madeira, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3754-3754
Open Access | Times Cited: 13

Indole alkaloids from marine resources: Understandings from therapeutic point of view to treat cancers
Fahadul Islam, Zerrouki Dehbia, Mehrukh Zehravi, et al.
Chemico-Biological Interactions (2023) Vol. 383, pp. 110682-110682
Closed Access | Times Cited: 13

Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells
Felix Neuhaus, Sonja Lieber, V. A. Shinkevich, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 4

Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options
Zoé Gabrielle Attal, Walid Shalata, Arina Soklakova, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1448-1448
Open Access | Times Cited: 4

Exosomal circ‐0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7/NRF2 axis
Minyu Zhuang, Xiaoqiang Zhang, Jie Ji, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4

Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH–Peptide Conjugates
Ildikó Szabó, Beáta Biri-Kovács, Balázs Vári, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1095-1095
Open Access | Times Cited: 3

Neurotransmitters: Impressive regulators of tumor progression
Yumei Yang, Lei Sun, Xuerou Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116844-116844
Open Access | Times Cited: 3

The dual roles of serotonin in antitumor immunity
Yingru Zhang, Yan Wang
Pharmacological Research (2024) Vol. 205, pp. 107255-107255
Open Access | Times Cited: 3

Tyrosinase‐Woven Melanin Nets for Melanoma Therapy through Targeted Mitochondrial Tethering and Enhanced Photothermal Treatment
Mian Tang, Tianshun Duan, Yunfeng Lu, et al.
Advanced Materials (2024) Vol. 36, Iss. 44
Open Access | Times Cited: 3

Hyperforin Enhances Heme Oxygenase-1 Expression Triggering Lipid Peroxidation in BRAF-Mutated Melanoma Cells and Hampers the Expression of Pro-Metastatic Markers
Alessia Cardile, Carlotta Passarini, Valentina Zanrè, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1369-1369
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top